TD Private Client Wealth LLC Buys 4,943 Shares of CME Group Inc. $CME

TD Private Client Wealth LLC boosted its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 118.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,123 shares of the financial services provider’s stock after acquiring an additional 4,943 shares during the quarter. TD Private Client Wealth LLC’s holdings in CME Group were worth $2,465,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in CME. CPC Advisors LLC lifted its holdings in shares of CME Group by 2,710.8% in the third quarter. CPC Advisors LLC now owns 25,719 shares of the financial services provider’s stock valued at $6,949,000 after purchasing an additional 24,804 shares in the last quarter. First United Bank & Trust raised its position in CME Group by 1.5% in the 3rd quarter. First United Bank & Trust now owns 5,077 shares of the financial services provider’s stock valued at $1,372,000 after buying an additional 75 shares during the last quarter. Quent Capital LLC bought a new stake in CME Group in the 3rd quarter valued at approximately $171,000. Nordea Investment Management AB lifted its stake in CME Group by 11.5% in the 3rd quarter. Nordea Investment Management AB now owns 36,333 shares of the financial services provider’s stock valued at $9,901,000 after acquiring an additional 3,758 shares in the last quarter. Finally, Janney Capital Management LLC boosted its position in CME Group by 2.6% during the 3rd quarter. Janney Capital Management LLC now owns 11,409 shares of the financial services provider’s stock worth $3,083,000 after acquiring an additional 289 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 1.3%

Shares of NASDAQ:CME opened at $268.45 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $225.46 and a 52-week high of $290.79. The business’s 50 day simple moving average is $273.98 and its two-hundred day simple moving average is $271.78. The firm has a market cap of $96.80 billion, a P/E ratio of 26.01, a PEG ratio of 3.42 and a beta of 0.27.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the business earned $2.68 EPS. CME Group’s quarterly revenue was down 3.0% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is presently 48.45%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CME. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Piper Sandler boosted their price target on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. TD Cowen raised their price objective on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, October 23rd. Finally, Bank of America lifted their target price on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and an average price target of $291.06.

Get Our Latest Report on CME Group

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction on Tuesday, December 30th. The shares were bought at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the acquisition, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. This represents a 0.10% increase in their position. The SEC filing for this purchase provides additional information. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.